Hepion Pharmaceuticals implements 1-for-50 reverse stock split effective March 17, 2025

Hepion Pharmaceuticals, Inc.

Every 50 pre-split shares reclassified into 1 share; par value unchanged at $0.0001.
Authorized shares of common and preferred stock remain unchanged.
No fractional shares issued; stockholders receive cash in lieu of fractions.
Outstanding options and warrants adjusted proportionately; exercise prices increased.
New CUSIP number is 426897401; stock continues trading on Nasdaq Capital Market.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Hepion Pharmaceuticals, Inc.: Amended certificate of incorporation to effect a one-for-fifty reverse stock split (effective 2025-03-17).

Change: charter amendment
Effective: 2025-03-17

Exact text from the filing

the Company filed the Amendment with the Secretary of State of the State of Delaware. The Reverse Stock Split became effective in accordance with the terms of the Amendment at 4:01 pm Eastern Time on March 17, 2025 (the “Effective Time”).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Hepion Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-010921

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.